Company Filing History:
Years Active: 2014-2019
Title: Jesse Cedarbaum: Innovator in ALS and Hyperuricemia Treatments
Introduction
Jesse Cedarbaum is a notable inventor based in San Francisco, CA (US). She has made significant contributions to the fields of medicine and pharmacology, particularly in the treatment of amyotrophic lateral sclerosis (ALS) and hyperuricemia. With a total of 2 patents, Cedarbaum's work has the potential to impact many lives.
Latest Patents
Cedarbaum's latest patents include a method for treating ALS, which involves administering a therapeutically effective amount of riluzole and CK-2017357. This innovative approach aims to reduce the variability of riluzole exposure in subjects, decrease the total daily dose, and improve the overall treatment experience by minimizing adverse events. Additionally, she has developed methods for treating hyperuricemia and associated diseases, utilizing scyllo-inositol to effectively lower uric acid levels in individuals.
Career Highlights
Throughout her career, Cedarbaum has worked with prominent companies such as Cytokinetics, Inc. and Elan Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Cedarbaum has collaborated with esteemed colleagues, including John Mao and Fady Malik. These partnerships have fostered an environment of innovation and have led to the development of her impactful patents.
Conclusion
Jesse Cedarbaum's contributions to ALS and hyperuricemia treatments exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a significant figure in the field of pharmacology.